Webinars on-demand with open access! Part #1: Pharmacology by Prof Danilo Norata Part #2: Clinical by Prof Lale Tokgozoglu Acknowledgement EAS-LCN have independently organised all…
The EAS Young Investigator Awards 2025 celebrate outstanding early-career researchers for their exceptional contributions to atherosclerosis and related metabolic disorders. Each award, valued at €2,000,…
Society: New plans and changes coming after EAS Executive Committee meeting: a direction for the future With the EAS Executive Committee meeting on March 17…
Brussels, March 24, 2025: One in five people globally—over 1.4 billion individuals—are living with elevated Lipoprotein(a) (Lp(a)), a significant, yet widely undetected inherited cardiovascular risk…
Education: This is your opportunity to discover androgen therapies’ impact on cardiovascular health – join our webinar! Get ready for an eye-opening webinar! This is your…
Outreach: AtheroTalk: Inside Dr Mate Kiss’s award-winning atherosclerosis research This episode is a special one! We sit down for an inspiring conversation with Dr Mate Kiss,…
This episode is a special one! We sit down for an inspiring conversation with Dr Mate Kiss, winner of the Young Investigator Award in Basic…
TG-rich lipoproteins: stars or second advantage in the field of residual CV risk? by Prof. Alberto Zambon This presentation was given by Professor Alberto Zambon…
Education: Join those who have already registered and sign up for the first EAS webinar of 2025! Get the latest on androgen therapies and cardiovascular…
Education: Androgen therapy & cardiovascular risks: key insights for healthcare professionals – gain them by attending our webinar Androgen therapies play a crucial role in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
